SCHEMBL2188158

SCHEMBL2188158

CCNC(=O)S(=O)(=O)Nc1sc(CC(C)C)cc1-c1ccc(Cn2c(-c3ccccc3)nc(C=O)c2OC)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAS1 P04201 1/20 0.60
▸ AGTR2 P50052 13/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ GMNN O75496 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ APEX1 P27695 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ THPO P40225 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1334134 0.90 MAS1 (0.74) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL29701254 0.89 MAS1 (0.73) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL3975878 0.89 MAS1 (0.73) MAS1AGTR2MEN1GMNNUSP2
Tromethamine SCHEMBL3912101 0.86 MAS1 (0.69) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL4102363 0.83 MAS1 (0.67) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL3906331 0.82 MAS1 (0.68) MAS1AGTR2MEN1GMNNUSP2
Lysine SCHEMBL3906133 0.82 MAS1 (0.63) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL3908044 0.81 MAS1 (0.69) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL3915251 0.80 MAS1 (0.69) MAS1AGTR2MEN1GMNNUSP2
SCHEMBL4099345 0.79 MAS1 (0.66) MAS1AGTR2MEN1GMNNUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4284779-A1 METHODS AND AGENTS THAT STIMULATE MITOCHONDRIAL TURNOVER FOR TREATING DISEASE Capacity Bio, Inc. (US) 2023-12-06 — — EP disclosed
EP-2341938-A2 USE OF AN ANG-(1-7) RECEPTOR AGONIST IN ACUTE LUNG INJURY Charité - Universitätsmedizin Berlin (DE) 2011-07-13 — — EP disclosed
WO-2010028845-A2 USE OF AN ANG-(1-7) RECEPTOR AGONIST IN ACUTE LUNG INJURY CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN (DE) 2010-03-18 — — WO disclosed
Send feedback